Related references
Note: Only part of the references are listed.Association of Symptomatic Benign Prostatic Hyperplasia and Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence
Curtis A. Pettaway et al.
BJU INTERNATIONAL (2011)
The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
Cosimo De Nunzio et al.
EUROPEAN UROLOGY (2011)
Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
Jeannette M. Schenk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Combination Therapy With Doxazosin and Tenoxicam for the Management of Lower Urinary Tract Symptoms
Ismail Ozdemir et al.
UROLOGY (2009)
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial
Alan R. Kristal et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
J. Curtis Nickel et al.
EUROPEAN UROLOGY (2008)
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Gero Kramer et al.
EUROPEAN UROLOGY (2007)
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial
Alan R. Kristal et al.
JOURNAL OF UROLOGY (2007)
Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia
Jennifer L. St Sauver et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention
KMC Verhamme et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Prevalence of conditions potentially associated with lower urinary tract symptoms in men
NM Gades et al.
BJU INTERNATIONAL (2005)
Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III)
S Rohrmann et al.
PROSTATE (2005)
Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)
F Di Silverio et al.
EUROPEAN UROLOGY (2005)
Risk behaviours and benign prostatic hyperplasia
D Kang et al.
BJU INTERNATIONAL (2004)
Aua guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations
JOURNAL OF UROLOGY (2003)
The influence of finasteride on the development of prostate cancer
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men
JB Meigs et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
The natural history of benign prostatic hyperplasia: What have we learned in the last decade?
RS Kirby
UROLOGY (2000)
Share Paper
